Market Overview

Benchmark Company Reiterates Buy Rating, $87 PT on Analogic Corporation

Related ALOG
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS
Mid-Day Gainers From December 10: Layne Christensen, Keurig Green Mountain, Burlington Stores And More

In a report published Wednesday, Benchmark Company reiterated its Buy rating and $87.00 price target on Analogic Corporation (NASDAQ: ALOG).

Benchmark Company noted, “We believe that there is the opportunity for expense reductions in general and administrative expenses. We also believe, to a smaller degree that there is an opportunity for expense reductions in both manufacturing expenses and in research and development expenses. We do not believe that ALOG will focus on expense reductions within sales and marketing as the larger distribution channel is a driver in this transaction. Ultrasonix is a profitable company and while we believe that ALOG made the acquisition to gain the expanded product line and the expanded distribution channel, we also believe that over time, ALOG will be able to reduce expenses where there is overlap. We believe Ultrasonix had approximately 130 employees.”

Analogic Corporation closed on Tuesday at $74.60.

Latest Ratings for ALOG

Sep 2014Brean CapitalDowngradesBuyHold
Jun 2014BenchmarkMaintainsBuy
Mar 2014CJS SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for ALOG
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Reiteration Analyst Ratings


Related Articles (ALOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content